音量 2, 問題 2 (2012)
臨床試験の方法論
Trial discontinuation: lessons for future trial design?
Veerle JAA Nuij, Colin J de Haar & C Janneke van der Woude
レビュー: 臨床試験の結果
Clinical evidence of the role of edoxaban in anticoagulation
Elena Fortuny ,Jose Zamorano
臨床試験の方法論
Outcome measures for clinical trials assessing treatment of cystic fibrosis lung disease
Donald R VanDevanter,Michael W Konstan
臨床試験の方法論
New considerations in the design of clinical trials for traumatic brain injury
Bob Roozenbeek, Hester F Lingsma Andrew I R Maas
研究の最新情報
Methodology for the Development of Innovative Cancer Therapies Task Force addresses methodological issues in the clinical development of innovative cancer therapies
Marinus W Lobbezoo, A Hilary Calvert, Elizabeth A Eisenhauer,Giuseppe Giaccone
レビュー: 臨床試験の結果
Telaprevir in the treatment of hepatitis C infection: evidence from the ADVANCE, ILLUMINATE and REALIZE studies
Joseph Ahn, Steven Flamm
レビュー: 臨床試験の結果
Clinical evidence for the role of eribulin mesylate in the treatment of breast cancer
Carole Gourmelon, Jean Sebastien Frenel,Mario Campone
臨床試験の展望
Research involving pregnant women: trials and tribulations
Francoise Baylis, Scott A. Halperin
治療的観点
Emergence of Neisseria meningitidis W-135 in the context of other rare serogroups
Luiz Jacintho da Silva, Lisa DeTora, Claudius Malerczyk & Ziad A Memish
